fashion -WSS

fashion

author：comprehensive 2025-08-23 08:12:36 - browse：7136

Sarepta - Cambridge -AP — A logo sign outside of the headquarters of Sarepta Therapeutics in Cambridge, Mass. Kristoffer Tripplaar/Sipa via AP

Reviewers at the Food and Drug Administration were leaning toward rejecting a closely watched gene therapy for Duchenne muscular dystrophy made by Sarepta Therapeutics, prompting a top official to intervene earlier this year, according to three people with direct knowledge of the agency deliberations.

Inside the FDA office that oversees gene therapies, some staff had reached a non-binding conclusion that Sarepta’s gene therapy should be rejected, the individuals said, speaking on condition of anonymity. Peter Marks, a top FDA official and vocal advocate for faster gene therapy approvals, stepped in and directed staff to schedule a public hearing on the therapy on May 12.

Sarepta announced the scheduling of the public hearing last month, but the internal deliberations that led to it have not been previously reported.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Home health providers sue Medicare over payment cuts

knowledge

entertainment

WSS

Gene therapy’s promise and the high cost of hope

The health care issue Democrats can’t solve: hospital reform

How to convince healthy people to buy insurance

Rikers Island jail violence not addressed, NYC should be held in contempt: Fed monitor

Bank of America ordered to pay more than $100 million for double charging fees, withholding rewards

The health care issue Democrats can’t solve: hospital reform

focus

fashion

leisure time

BioMarin wins approval for gene therapy to treat hemophilia A

Wisconsin governor employs partial veto to fund schools for 4 centuries

What does generative AI mean for health care? We asked experts

Life sciences investors close nearly $6 billion in new funds

Jerome Adams on the need for new antivirals for Covid

Gene therapy’s promise and the high cost of hope

At least 13 dead in Texas as scorching temps continue

‘Insidious 5’ topples 'Indiana Jones' before ‘Mission: Impossible’ launches

Hepatitis C has a cure — but many Americans still lack access to it

Judge agrees to delay next hearing in Trump classified documents case

focus

Readout LOUD podcast: ESMO highlights & Roivant's big deal

Infant mortality in U.S. rose last year for first time in decades: CDC

Create a giant ice tray with this foil pan hack to keep food cold this summer

Swim instructor mom warns parents not to buy blue swimsuits for kids

How neuroscience research could help beat back brain cancer

Rikers Island jail violence not addressed, NYC should be held in contempt: Fed monitor

knowledge

entertainment

entertainment

focus